ovarian cancers and then reviewed recommendations for its use in certain clinical scenarios. Endometrial Cancer The most common gynecologic malignancy is endometrial cancer; approximately 75% of these cancers are early-stage tumors. Many of these
Search Results
Lisa I. Iezzoni, Sowmya R. Rao, Nicole D. Agaronnik, and Areej El-Jawahri
Other Variables Sample Adult Core respondents were asked “if they have ever been told by a doctor that they had cancer,” and if so, the type of cancer. We considered 4 cancer types: colorectal cancer (CRC), non-Hodgkin’s lymphoma (NHL), ovarian cancer
Pamela J. DiPiro
, “with minimal, if any, risk of missing thoracic metastasis.” In a separate study, Shinagare et al 8 created an evidence-based prediction rule to optimize the use of chest CT in patients with ovarian cancer. In this retrospective study performed at 2
Kelly Bontempo, Chloe Wernecke, Brenna Bentley, Krista Ortega, Jessica Kreamer, Rakesh Patel, and Peter Beitsch
and cover testing, rather than other available guidelines or clinical intuition, miss an opportunity for personalized cancer risk management. This may affect both treatment and prevention strategies. As NCCN qualifies all patients with ovarian cancer
Available for Ovarian Cancer NCCN has published updated NCCN Guidelines for Patients and NCCN Quick Guide sheets for Ovarian Cancer. Funding for these resources was provided through the NCCN Foundation and, in part, through generous sponsorship from
and summarized emerging data with novel agents and combination regimens for the diseases. Following Dr. Treon, Robert J. Morgan, MD, City of Hope Comprehensive Cancer Center, explored recurrence therapy for ovarian cancer, outlining specific
Amanda M. Cook, David F. Keren, Lynn McCain, Lee F. Schroeder, Kara Milliron, Sofia Merajver, Diane Harper, Philip Zazove, Janice Farrehi, Susan Ernst, and Jasmine Parvaz
Breast and Ovarian Cancer Risk Evaluation Clinic (BOCREC). Patients were invited to complete InheRET by giving them a link to www.inheret.org . Once patients completed their health history, a user experience survey immediately followed. The experience
Steven M. Grunberg
1983 ; 19 : 203 – 208 . 3 Sun CC Bodurka BC Weaver CB . Rankings and symptom assessments of side effects of chemotherapy: insights from experienced patients with ovarian cancer . Support Care Cancer 2005 ; 13 : 219 – 227 . 4
Crystal Denlinger and Terry S. Langbaum
. Cancers in which close surveillance may not change outcome include pancreas, gastric, and perhaps ovarian cancers. Colorectal Cancer Colorectal cancer surveillance with carcinoembryonic antigen (CEA) testing and CT scanning improves the possibility
Soumyajit Roy, Paul Hoskins, Anna Tinker, Harinder Brar, Gale Bowering, and Gaurav Bahl
, 1984, and December 31, 2015. The provincial cancer registry and ovarian cancer outcome unit were used to identify patients. These centers follow the guidelines set by the provincial authority overseeing the delivery of cancer care in a province of 4